Pfiz­er's off the hook af­ter fed­er­al judge dis­miss­es pro­posed law­suit over Chan­tix re­calls

Pfiz­er can breathe a lit­tle eas­i­er af­ter a fed­er­al judge on Wednes­day dis­missed a pro­posed class-ac­tion law­suit over sev­er­al re­called batch­es of its pop­u­lar smok­ing ces­sa­tion drug Chan­tix.

The le­gal bat­tle dates back to June when Pfiz­er halt­ed dis­tri­b­u­tion of Chan­tix af­ter find­ing el­e­vat­ed lev­els of a po­ten­tial car­cino­gen. In Ju­ly, the phar­ma gi­ant had re­called nine lots of the drug due to con­t­a­m­i­na­tion from N-ni­troso-vareni­cline — a chem­i­cal com­pound that sci­en­tists say has the po­ten­tial to cause can­cer.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER